PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.\', \'Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy.\', \'Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.\', \'Clinical and Experimental Endocrinology (CEE), Katholieke Universiteit Leuven (KULEUVEN), Leuven, Belgium.\', \'ULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, Brussels, Belgium.\', \'Indiana Biosciences Research Institute, Indianapolis, IN, United States.\', \'Tuscany Centre for Precision Medicine (CReMeP), Siena, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fendo.2020.596898
?:doi
?:hasPublicationType
?:journal
  • Frontiers in endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 33281748
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.79
?:rankingScore_hIndex
  • 42
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all